SAMUEL BANIGO: Open Payments
NPI 1063503555 · IRVINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 8 payments from 4 companies in 2025. Trend: 2023 $36 · 2024 $147 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 4 | $70 |
| Novo Nordisk Inc | 2 | $44 |
| Lilly USA, LLC | 1 | $17 |
| ACADIA Pharmaceuticals Inc | 1 | $16 |
Products named: NUZYRA, Ozempic, JARDIANCE, NUPLAZID.
Industry payments across NJ — which companies pay providers there.
